Low-dose aspirin, an anti-platelet drug, is an excellent choice for many. Aspirin is classed as a non-steroidal anti inflammatory drug. This means that it reduces inflammation but does not contain steroids. Aspirin is a drug that is very familiar to most people. It’s a medication that most of us have taken at one time or…
Integrative treatment means bringing the best of conventional medicine together with the best of therapies from other traditions. This approach looks at your health as a whole and from many different perspectives. Consider your overall needs In the case of MPNs, integrative treatment means looking past your blood counts and the medication you take to…
Anagrelide can be used to treat Essential Thrombocythaemia (ET), Polycythaemia Vera (PV) and Myelofibrosis (MF). Anagrelide is one possible drug that your haematologist may recommend to treat your MPN. In Europe, Anagrelide is licensed as a second line treatment ––the medication hydroxycarbamide [hydroxycarbamide treatments] is prescribed as a first-line treatment. If hydroxycarbamide is not suitable…
Download detailed information here about myeloproliferative neoplasm (MPN) treatments. The treatment and disease leaflets are A5 sized, these can be printed onto single sided A4 paper (US substitute letter or legal) or in booklet form. You can download detailed instructions and illustrations for printing a booklet here, or follow the instructions for your own printer. If…
Epidemiology There is little information about what causes myeloproliferative neoplasms (MPNs). Patients often ask, “why do I have this disease?”, and for the majority there is no obvious reason. The MOSAICC study (MyelOproliferative neoplasmS: An In-depth Case-Control) is a UK-wide study that aims to identify what causes myeloproliferative neoplasms (MPNs) and the best way to…
Many people with MPNs wonder what causes these blood cancers. Some researchers believe that viral infections, exposure to toxins, exposure to radiation or something else may cause myeloproliferative neoplasms by causing a change in the genetic code of the bone marrow cells. Unfortunately current research still does not offer any proof as to what causes…
You may think that MPN research is primarily focused on investigating new drugs for better blood control in essential thrombocythaemia (ET), myelofibrosis (MF) or polycythaemia vera (PV) and ones that offer patients a longer and better quality of life, indeed eventually hopefully a cure. However there are also a number of projects researching why patients…
MPNs are rare blood cancers that affect how blood cells are produced in our bodies. Our bodies normally produce billions of blood cells every day. This process occurs inside our bones, in the bone marrow. The bone marrow contains stem cells which grow and mature into all the blood cells that our bodies need: Red…